SCHEMBL21185502

SCHEMBL21185502

O=C1C=CC(=O)C2=C1SC(=C1C(=O)N(CCCl)N(CCCl)C1=O)S2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21185503 0.82 MEN1 (0.32) —
SCHEMBL21185462 0.79 ALDH1A1 (0.36) —
SCHEMBL21185494 0.79 — —
SCHEMBL21185500 0.78 ALDH1A1 (0.35) —
SCHEMBL21185415 0.77 MGLL (0.42) —
SCHEMBL21185508 0.77 GSK3A (0.40) —
SCHEMBL21185509 0.76 ALDH1A1 (0.33) —
SCHEMBL21185498 0.76 GSK3B (0.44) —
SCHEMBL21185519 0.75 — —
SCHEMBL21185492 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019142538-A1 COMPOSITION, CURABLE COMPOSITION, AND COMPOUND 富士フイルム株式会社 2019-07-25 — — WO disclosed
Send feedback